The Abbott EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter, Sensor Enabled to map cardiac arrhythmias during ablation treatments has been used for the first time in the United States.
Electrophysiologist Dr. John Day was the first American doctor to use the system during an ablation after the U.S. Food and Drug Administration's approval. The first use was at the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City.
"The new EnSite Precision cardiac mapping system allows better three-dimensional images of the arrhythmias in the heart, which improve the accuracy of what we see during the procedure so we can more precisely treat the patient," Day, medical director of the Intermountain Heart Rhythm Specialists, said. "We were excited to perform the inaugural case in the United States, and we continue to utilize the system daily to provide the best patient care possible."
Abbott hopes the new technology will become the standard in treating complicated arrhythmias, especially after procedures occurred in 12 more states after Day’s initial use.
"This next-generation technology was designed in collaboration with some of the world's leading electrophysiologists so that they can quickly and precisely identify the source and substrate source of a patient's irregular heartbeat," Dr. Srijoy Mahapatra, medical director and vice president of Medical Affairs for Abbott's electrophysiology business, said. "We expect the EnSite Precision cardiac mapping system to become the new standard for identifying abnormal heart rhythms when tailoring treatment for patients suffering from arrhythmias."
